SCHEMBL21113696

SCHEMBL21113696

CC(=O)c1cccc(/C(C)=N/c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 4/20 0.43
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
ALOX12 P18054 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CRHR1 P34998 1/20 0.38
LMNA P02545 1/20 0.37
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589473 0.91 NOS1 (0.50) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL5589476 0.91 NOS1 (0.50) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL17489134 0.90 KDM4E (0.59) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL5589766 0.89 NOS1 (0.48) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL15082887 0.89 NOS1 (0.48) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL7171334 0.87 NOS1 (0.47) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL7182691 0.87 NOS1 (0.47) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL7179350 0.87 NOS1 (0.47) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL7176633 0.87 NOS1 (0.47) KDM4EALOX15TSHRACMSDTDP1
Hydrochloric Acid SCHEMBL7175793 0.87 NOS1 (0.47) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3517555-B1 CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2024-11-27 EP claimed
EP-3517555-A1 CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF China Petroleum&Chemical Corporation (CN) 2019-07-31 EP claimed
US-20190211119-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST, AND USE THEREOF BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-07-11 US claimed
EP-3517555-B1 CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF CHINA PETROLEUM & CHEM CORP (CN) 2024-11-27 EP disclosed
US-11325994-B2 Catalyst component for olefin polymerization, catalyst, and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-05-10 US disclosed
US-20220008347-A1 Self-Assembled Microcapsules With Stimuli-Responsive Organic Ligands THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-01-13 US disclosed
EP-3517555-A1 CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF China Petroleum&Chemical Corporation (CN) 2019-07-31 EP disclosed
US-20190211119-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST, AND USE THEREOF BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220008347-A1 Self-Assembled Microcapsules With Stimuli-Responsive Organic Ligands MLEC, MSN, EPHA2 KDM4E 4122/4885ALOX15 707/4885TSHR 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.